194 related articles for article (PubMed ID: 8265661)
1. Allele-specific peptide ligand motifs of HLA-C molecules.
Falk K; Rötzschke O; Grahovac B; Schendel D; Stevanović S; Gnau V; Jung G; Strominger JL; Rammensee HG
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):12005-9. PubMed ID: 8265661
[TBL] [Abstract][Full Text] [Related]
2. Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries.
Dionne SO; Lake DF; Grimes WJ; Smith MH
Immunogenetics; 2004 Sep; 56(6):391-8. PubMed ID: 15309347
[TBL] [Abstract][Full Text] [Related]
3. Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule.
Rasmussen M; Harndahl M; Stryhn A; Boucherma R; Nielsen LL; Lemonnier FA; Nielsen M; Buus S
J Immunol; 2014 Nov; 193(10):4790-802. PubMed ID: 25311805
[TBL] [Abstract][Full Text] [Related]
4. Definition of peptide binding motifs amongst the HLA-A*30 allelic group.
Krausa P; Münz C; Keilholz W; Stevanovic S; Jones EY; Browning M; Bunce M; Rammensee HG; McMichael A
Tissue Antigens; 2000 Jul; 56(1):10-8. PubMed ID: 10958351
[TBL] [Abstract][Full Text] [Related]
5. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells.
Colonna M; Borsellino G; Falco M; Ferrara GB; Strominger JL
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):12000-4. PubMed ID: 8265660
[TBL] [Abstract][Full Text] [Related]
6. A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities.
Chelvanayagam G
Immunogenetics; 1996; 45(1):15-26. PubMed ID: 8881033
[TBL] [Abstract][Full Text] [Related]
7. Natural ligand motifs of H-2E molecules are allele specific and illustrate homology to HLA-DR molecules.
Schild H; Grüneberg U; Pougialis G; Wallny HJ; Keilholz W; Stevanović S; Rammensee HG
Int Immunol; 1995 Dec; 7(12):1957-65. PubMed ID: 8746565
[TBL] [Abstract][Full Text] [Related]
8. Nonclassical HLA-G molecules are classical peptide presenters.
Diehl M; Münz C; Keilholz W; Stevanović S; Holmes N; Loke YW; Rammensee HG
Curr Biol; 1996 Mar; 6(3):305-14. PubMed ID: 8805247
[TBL] [Abstract][Full Text] [Related]
9. Definition of specific peptide motifs for four major HLA-A alleles.
Kubo RT; Sette A; Grey HM; Appella E; Sakaguchi K; Zhu NZ; Arnott D; Sherman N; Shabanowitz J; Michel H
J Immunol; 1994 Apr; 152(8):3913-24. PubMed ID: 8144960
[TBL] [Abstract][Full Text] [Related]
10. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis.
Zappacosta F; Borrego F; Brooks AG; Parker KC; Coligan JE
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6313-8. PubMed ID: 9177214
[TBL] [Abstract][Full Text] [Related]
11. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
[TBL] [Abstract][Full Text] [Related]
12. Several HLA alleles share overlapping peptide specificities.
Sidney J; del Guercio MF; Southwood S; Engelhard VH; Appella E; Rammensee HG; Falk K; Rötzschke O; Takiguchi M; Kubo RT
J Immunol; 1995 Jan; 154(1):247-59. PubMed ID: 7527812
[TBL] [Abstract][Full Text] [Related]
13. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.
Davenport MP; Quinn CL; Chicz RM; Green BN; Willis AC; Lane WS; Bell JI; Hill AV
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6567-71. PubMed ID: 7604034
[TBL] [Abstract][Full Text] [Related]
14. HLA class I self peptides isolated from a T-cell leukemia reveal the allele-specific motif of HLA-B38.
Colovai AI; Suciu-Foca N; Baiulescu GE; Harris PE
Tissue Antigens; 1994 Aug; 44(2):65-72. PubMed ID: 7817380
[TBL] [Abstract][Full Text] [Related]
15. Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices.
Di Marco M; Schuster H; Backert L; Ghosh M; Rammensee HG; Stevanović S
J Immunol; 2017 Oct; 199(8):2639-2651. PubMed ID: 28904123
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of beta 2-microglobulin from HLA class I heavy chains correlates with acquisition of epitopes in the cytoplasmic tail.
Little AM; Nössner E; Parham P
J Immunol; 1995 May; 154(10):5205-15. PubMed ID: 7537301
[TBL] [Abstract][Full Text] [Related]
17. Studies on binding of HIV-1 p24gag peptide to HLA-Cw3+ cells.
Kość A; Dubis J; Wojciechowska I; Maćkiewicz Z; Gorczyca W; Myc A; Kupryszewski G; Mańczak M; Myc P; Kuśnierczyk P
Immunol Lett; 1998 Dec; 64(2-3):57-62. PubMed ID: 9870655
[TBL] [Abstract][Full Text] [Related]
18. Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis.
Malcherek G; Falk K; Rötzschke O; Rammensee HG; Stevanović S; Gnau V; Jung G; Melms A
Int Immunol; 1993 Oct; 5(10):1229-37. PubMed ID: 8268130
[TBL] [Abstract][Full Text] [Related]
19. Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket.
Kikuchi A; Sakaguchi T; Miwa K; Takamiya Y; Rammensee HG; Kaneko Y; Takiguchi M
Immunogenetics; 1996; 43(5):268-76. PubMed ID: 9110930
[TBL] [Abstract][Full Text] [Related]
20. HLA-B15 peptide ligands are preferentially anchored at their C termini.
Prilliman KR; Jackson KW; Lindsey M; Wang J; Crawford D; Hildebrand WH
J Immunol; 1999 Jun; 162(12):7277-84. PubMed ID: 10358176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
